Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-inflammatory Medications

NCT02583672 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT02583672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02583672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-inflammatory Medications
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2015
Completion date
December 31, 2025
Enrollment
33 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher disease type 1